Search Results 631-640 of 18271 for SARS

  1. A Study Evaluating The Safety, Efficacy, And Pharmacokinetics Of Mosunetuzumab And A Combined Regimen Of Mosunetuzumab And Venetoclax In Participants With Relapsed Or Refractory Chronic Lymphocytic Leukemia - Mayo Clinic

    ... SARS-CoV-2), fungal, mycobacterial, parasitic, or other infection (excluding fungal infections of nail beds) at study enrollment * Evidence of any ...

  2. A Study to Evaluate the Safety and Effectiveness of Upadacitinib (ABT-494) in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Confirmed COVID-19: the Baseline visit must be at least 14 days from onset of signs/symptoms or positive SARS-CoV-2 test, symptomatic subjects must have ...

  3. Publications - Nessa Aghazadeh Mohandesi, M.D. - Mayo Clinic

    New-onset pemphigus foliaceus following sars-cov-2 infection and unmasking multiple sclerosis: a case report. Clinical Case Reports. 2022 Jun; 10 (6):e05910

  4. History of Zika virus: Outbreaks and vaccine timeline

    Coronavirus vaccine development: From SARS and MERS to COVID-19. Journal of Biomedical Science. 2020; doi:10.1186/s12929-020-00695-2. Dolgin E. The tangled ...

  5. Vaccine Research Group: Gregory A. Poland, Richard B. Kennedy, Inna G. Ovsyannikova

    SARS-CoV-2 · Influenza · Measles · Rubella · Smallpox · Training and education. Researchers in the Vaccine Research Group at Mayo Clinic study the genetic ...

  6. Rituximab and hyaluronidase human, recombinant (subcutaneous route) - Side effects & uses - Mayo Clinic

    SARS-COV-2 (COVID-19) Vaccine, Adenovirus 26 Vector (Janssen); SARS-COV-2 (COVID-19) Vaccine, mRNA (Moderna); SARS-COV-2 (COVID-19) Vaccine, mRNA (Pfizer) ...

  7. Viral Hepatitis Clinical Trials - Mayo Clinic Research

    The purpose of this study is to better understand the role of HIV and/or HCV infection and/or SARS-CoV-2 on the immune system and potential ways to ...

  8. Publications - Cumara B. O'Carroll, M.D., M.P.H. - Mayo Clinic

    Stroke Features, Risk Factors, and Pathophysiology in SARS-CoV-2-Infected Patients. Mayo Clin Proc Innov Qual Outcomes. 2022 Apr; 6 (2):156-165 Epub 2022 ...

  9. Publications - Aziza Nassar, M.D., M.P.H. - Mayo Clinic

    ... SARS-CoV-2. Lab Med. 2022 Nov 3; 53 (6):580-584. View PubMed; David J, Baird BA, Nassar A, Geldmaker L, Broderick GA. A rare case of BK virus non-hemorrhagic ...

  10. Health Coaching and Recovery from Post-COVID Syndrome in Adolescents - Mayo Clinic

    No prior positive SARS-CoV2 testing. Age ≥ 18 years at time of initial clinical evaluation. Note: Other protocol defined Inclusion/Exclusion Criteria may ...